Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Kosan Biosciences describes compounds for gastrointestinal motility disorders

Aug. 27, 2002

Incara stops patient enrollment in deligoparin trial

Aug. 27, 2002

5-ASA-containing prodrugs for IBD presented at ACS

Aug. 27, 2002

Aphton seeks E.U. clearance for G17DT trial in GERD

Aug. 26, 2002

FDA issues non approval letter for Helicide

Aug. 23, 2002

Thalidomide reported to be effective in the short-term treatment of symptomatic IBD

Aug. 23, 2002

Successful treatment of severe alcoholic hepatitis with urinastarine

Aug. 22, 2002

Adolor enters opioid antagonist license agreement with Lilly

Aug. 20, 2002

FDA approves pediatric labeling of Prevacid

Aug. 9, 2002

HCV NS3 protease inhibitors prepared and tested at Schering-Plough

Aug. 8, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...